Related Experiment Video
Updated: Dec 19, 2025
07:36
Tumor Transplantation for Assessing the Dynamics of Tumor-Infiltrating CD8+ T Cells in Mice
Published on: June 12, 2021
7.3K
Th9 Cell Differentiation and Its Dual Effects in Tumor Development
Tao Chen1,2, Jufeng Guo3, Zhenhai Cai4
1Department of Orthopedics, Musculoskeletal Tumor Center, The Second Affiliated Hospital of Zhejiang University School of Medicine, Hangzhou, China.
Frontiers in Immunology
|June 9, 2020
Summary
Th9 cells, a type of CD4+ T helper cell, show potent anti-tumor properties against solid tumors. This review explores Th9 cell differentiation and their dual role in cancer progression.
Area of Science:
- Immunology
- Oncology
- Cellular Biology
Background:
- The immune system's role in cancer prevention is increasingly recognized.
- Current cancer immunotherapies, like adoptive cell therapy (ACT), show promise but have limitations.
- Focus has been on CD8+ cytotoxic T lymphocytes, leaving CD4+ T cell roles less explored.
Purpose of the Study:
- To review recent advances in understanding Th9 cell differentiation.
- To explore the dual role of Th9 cells in tumor progression (both anti-tumor and pro-tumor effects).
- To highlight Th9 cells as a potential cellular therapy for cancer.
Main Methods:
- Literature review of recent studies on Th9 cell biology and cancer immunology.
- Analysis of Th9 cell differentiation pathways and mechanisms of action.
- Synthesis of data on Th9 cell efficacy in preclinical and clinical cancer models.
Main Results:
- Th9 cells, defined by IL-9 and IL-10 secretion, demonstrate significant anti-tumor activity.
- Th9 cells exhibit superior anti-tumor properties compared to Th1 and Th17 cells in certain contexts.
- Th9 cells can exert both beneficial (anti-tumor) and detrimental (pro-tumor) effects in the tumor microenvironment.
Conclusions:
- Th9 cells represent a promising cellular component for cancer immunotherapy.
- Further research into Th9 cell differentiation and function is crucial for optimizing their therapeutic potential.
- Understanding the dual role of Th9 cells is key to harnessing their anti-tumor capabilities while mitigating pro-tumor effects.
Related Concept Videos
02:53Adaptive Mechanisms in Cancer Cells
6.8K
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
6.8K
02:40Cancer Stem Cells and Tumor Maintenance
5.8K
Early diagnosis and treatment can often cure cancer. However, even with treatment, residual cells called cancer stem cells (CSC) might remain, often causing tumor recurrence. These cancer stem cells possess the potential for self-renewal and multi-lineage differentiation and are often responsible for the therapeutic resistance displayed in most cancers.
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
5.8K
02:23Abnormal Proliferation
5.0K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
5.0K
02:07Tumor Progression
7.1K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
7.1K
01:24T Cell Types and Functions
2.0K
When T cells with CD4 markers are activated, they give rise to two types of effector cells: helper T cells and regulatory T cells. Meanwhile, T cells with CD8 markers differentiate into effector cytotoxic T cells. The differentiation of CD4 T cells into helper T cell subsets, such as Th1, Th2, and Th17 cells, is dependent on the antigen type, antigen-presenting cell, and regulatory cytokines.
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
2.0K
02:17The Tumor Microenvironment
7.5K
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
7.5K